Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Beclomethasone Dipropionate
Generic Name
Beclomethasone Dipropionate
Active Ingredient
Beclomethasone DipropionateCategory
Other
Variants
2
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 40 ug/1 | AEROSOL, METERED | RESPIRATORY (INHALATION) | 69238-1289 |
| 80 ug/1 | AEROSOL, METERED | RESPIRATORY (INHALATION) | 69238-1290 |
References used for this content
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Beclomethasone Dipropionate, you must consult a qualified healthcare professional.
Detailed information about Beclomethasone Dipropionate
Beclomethasone Dipropionate is a potent corticosteroid used primarily for the long-term management of chronic asthma, allergic rhinitis, and certain inflammatory bowel conditions. It works by reducing inflammation and suppressing immune responses in targeted tissues.
Dosage for Beclomethasone Dipropionate is highly individualized based on the severity of the condition and the specific formulation used.
Specific dosage adjustments for patients with kidney disease are generally not required for inhaled or nasal Beclomethasone Dipropionate, as systemic absorption is low. However, patients with severe renal impairment should be monitored for systemic corticosteroid effects if taking oral formulations.
Because the liver is involved in the metabolism of the swallowed portion of the drug and the clearance of the active metabolite, patients with significant liver disease (e.g., cirrhosis) may experience higher systemic levels. While specific dose reduction protocols are not standardized for inhalers, clinical monitoring for signs of hypercorticism (Cushingoid features) is recommended.
No overall differences in safety or effectiveness have been observed between elderly patients and younger patients. However, because older adults are more prone to decreased bone mineral density and cataracts, the lowest effective dose should be prioritized.
Proper technique is critical for the efficacy of Beclomethasone Dipropionate:
If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up.
Acute overdose of inhaled Beclomethasone Dipropionate is unlikely to be life-threatening. However, chronic over-utilization can lead to systemic corticosteroid effects, such as HPA (hypothalamic-pituitary-adrenal) axis suppression, which can cause extreme fatigue, muscle weakness, and fainting. If someone swallows the contents of a canister or takes an excessive amount of oral tablets, contact a poison control center or seek emergency medical care immediately.
> Important: Follow your healthcare provider's dosing instructions precisely. Do not adjust your dose or stop the medication without medical guidance, as sudden discontinuation can lead to a return of symptoms.
Side effects of Beclomethasone Dipropionate are often localized to the site of administration. For inhaled versions, the most common issues include:
Beclomethasone Dipropionate is a long-term maintenance medication. It is not a bronchodilator and should never be used as a rescue medication for acute asthma attacks (bronchospasm). Patients must always have a fast-acting rescue inhaler (such as albuterol) available for sudden symptoms.
No FDA black box warnings for Beclomethasone Dipropionate. The most critical safety concern remains the risk of adrenal crisis when transitioning from oral steroids to inhaled forms, as the inhaled form does not provide the systemic steroid levels the body may have become dependent upon.
While there are few absolute contraindications for inhaled Beclomethasone, it should not be used with:
Beclomethasone Dipropionate must NEVER be used in the following circumstances:
FDA Pregnancy Category C (under the older system). There are no adequate and well-controlled studies in pregnant women. However, poorly controlled asthma during pregnancy poses significant risks to both the mother (preeclampsia, gestational hypertension) and the fetus (premature birth, low birth weight).
Data from observational studies suggest that inhaled Beclomethasone is generally considered one of the preferred corticosteroids for managing asthma during pregnancy when a steroid is necessary. However, it should only be used if the potential benefit justifies the potential risk to the fetus. Infants born to mothers who received substantial doses of corticosteroids during pregnancy should be carefully observed for signs of hypoadrenalism (underactive adrenal glands).
It is not known whether Beclomethasone Dipropionate is excreted in human milk. However, other corticosteroids are known to pass into breast milk in small amounts. Because the systemic levels of Beclomethasone are very low following inhalation or nasal administration, the amount a nursing infant would receive is likely negligible. Nevertheless, caution should be exercised, and breastfeeding mothers should discuss the timing of their doses and the health of their infants with a pediatrician.
Beclomethasone Dipropionate is a potent glucocorticoid receptor agonist. It is a prodrug with weak receptor affinity that is rapidly converted by esterases to beclomethasone-17-monopropionate (17-BMP), which has a high affinity for glucocorticoid receptors. The 17-BMP metabolite works by binding to the glucocorticoid receptor in the cytoplasm. The resulting complex moves into the nucleus and binds to GREs, leading to the suppression of inflammatory genes (like those for IL-6 and TNF-alpha) and the induction of anti-inflammatory genes (like Annexin A1). This results in reduced airway edema, decreased mucus secretion, and inhibited recruitment of inflammatory cells.
Beclomethasone Dipropionate has a slow onset of action. Improvement in asthma control can occur within 24 hours of starting treatment, but maximum improvement may take 1 to 2 weeks or longer. It does not have an immediate bronchodilatory effect. The duration of effect is sufficient for twice-daily dosing in most patients. Tolerance to the anti-inflammatory effects of corticosteroids is generally not observed, though the underlying disease severity may change over time.
| Parameter | Value |
Common questions about Beclomethasone Dipropionate
Beclomethasone Dipropionate is primarily used as a long-term maintenance treatment for chronic asthma and allergic rhinitis. In asthma, it works by reducing inflammation in the airways to prevent wheezing and shortness of breath, though it is not a rescue inhaler. For allergic rhinitis, it is used as a nasal spray to relieve symptoms like sneezing, congestion, and a runny nose. Additionally, specific oral or rectal forms are used to treat inflammatory bowel diseases like ulcerative colitis. It is essential to use this medication regularly as prescribed by your doctor to see the full therapeutic benefit.
The most common side effects depend on how the medication is administered. For inhaled versions used in asthma, patients often experience oral thrush (a yeast infection), hoarseness, a sore throat, or a mild cough after use. Nasal spray users frequently report nosebleeds, nasal irritation, or a dry nose. If taken orally for colitis, side effects may include headache or nausea. Most localized side effects, like thrush, can be prevented by rinsing the mouth with water after each dose. Always report persistent or worsening side effects to your healthcare provider.
There is no known direct interaction between alcohol and inhaled or nasal Beclomethasone Dipropionate. However, alcohol can sometimes worsen the conditions the drug is treating, such as irritating the digestive tract in patients with ulcerative colitis. For asthma patients, heavy alcohol use may occasionally trigger respiratory symptoms in some individuals. It is generally advisable to consume alcohol only in moderation and to discuss your specific situation with your doctor. If you are taking oral steroid tablets, your doctor may provide more specific restrictions regarding alcohol.
Beclomethasone Dipropionate is often considered one of the safer corticosteroid options for managing asthma during pregnancy because it has a long track record of use. While it is officially categorized as a drug that should only be used if the benefits outweigh the risks, keeping asthma well-controlled is vital for the health of both the mother and the baby. Uncontrolled asthma can lead to complications like low birth weight or premature delivery. If you are pregnant or planning to become pregnant, your doctor will help you determine the lowest effective dose to manage your symptoms safely. Regular monitoring is recommended throughout the pregnancy.
Beclomethasone Dipropionate is not a fast-acting medication and does not provide immediate relief from symptoms. For asthma, some patients may notice a slight improvement in their breathing within 24 hours, but it typically takes 1 to 2 weeks of consistent use to reach the full anti-inflammatory effect. For nasal symptoms related to allergies, it may also take several days of regular use before you notice significant relief. Because it works by gradually reducing tissue swelling, it must be taken every day as directed, even if you feel fine. If your symptoms do not improve after two weeks, consult your healthcare provider.
You should not stop taking Beclomethasone Dipropionate suddenly without consulting your healthcare provider. Abruptly stopping the medication can cause your asthma or allergy symptoms to return quickly and potentially more severely. Furthermore, if you have been using high doses for a long time, your body may need time to adjust its natural hormone production. Your doctor will typically provide a tapering schedule to slowly reduce the dose, allowing your system to adapt safely. Always follow the specific discontinuation instructions provided by your medical professional.
If you miss a dose of Beclomethasone Dipropionate, you should take it as soon as you remember. However, if it is nearly time for your next scheduled dose, you should skip the missed dose and simply take the next one at the regular time. Do not take two doses at once to make up for the one you missed, as this can increase the risk of side effects. Consistency is key to the effectiveness of this medication, so try to use it at the same time each day. Setting a daily alarm or using a medication tracking app can help you stay on schedule.
Weight gain is a common side effect of oral corticosteroids (like prednisone), but it is much less common with inhaled or nasal Beclomethasone Dipropionate. Because the inhaled and nasal forms deliver the drug directly to the site of inflammation, very little of the medication enters the bloodstream. However, if the drug is used at very high doses over a long period, some systemic absorption can occur, which might lead to metabolic changes. If you are taking the oral tablet form for ulcerative colitis, the risk of weight gain is slightly higher than with the inhaler. Discuss any concerns about weight or appetite changes with your doctor.
Beclomethasone Dipropionate can be taken with many other medications, but some interactions require caution. For example, taking it with strong CYP3A4 inhibitors (like certain HIV medications or antifungals) can increase the levels of the steroid in your body, leading to more side effects. It is also important to tell your doctor if you are taking other forms of steroids, as the effects can add up. Most asthma patients use Beclomethasone alongside a 'rescue' inhaler like albuterol without issue. Always provide your healthcare provider with a full list of all prescriptions, over-the-counter drugs, and herbal supplements you use.
Yes, Beclomethasone Dipropionate is available in generic forms for several of its delivery methods, including nasal sprays and some inhalation aerosols. Generic versions are required by the FDA to have the same active ingredient, strength, and dosage form as the brand-name products. Availability may vary depending on your country and specific insurance plan. Using a generic version can often be a more cost-effective way to manage chronic conditions like asthma or allergies. Ask your pharmacist or doctor if a generic version is appropriate and available for the specific brand you were prescribed.
Other drugs with the same active ingredient (Beclomethasone Dipropionate)
> Warning: Stop taking Beclomethasone Dipropionate and call your doctor immediately if you experience any of these.
Chronic use of Beclomethasone Dipropionate, especially at high doses, may lead to systemic absorption and the following long-term effects:
No FDA black box warnings for Beclomethasone Dipropionate. However, there are significant warnings regarding the transfer of patients from systemic corticosteroid therapy (like prednisone) to inhaled Beclomethasone. Deaths due to adrenal insufficiency have occurred in asthmatic patients during and after transfer from systemic corticosteroids to less systemically available inhaled corticosteroids. During times of stress or a severe asthma attack, patients who have been transferred require immediate resumption of systemic steroids.
Report any unusual symptoms to your healthcare provider. Your doctor will weigh the benefits of inflammation control against these potential side effects.
Patients on long-term Beclomethasone Dipropionate may require the following monitoring:
Beclomethasone Dipropionate generally does not affect the ability to drive or operate machinery. However, if a patient experiences rare side effects like dizziness or vision changes, they should refrain from these activities until the symptoms resolve.
There is no direct contraindication between alcohol and inhaled Beclomethasone Dipropionate. However, for patients taking oral formulations for ulcerative colitis, alcohol may irritate the gastrointestinal tract and worsen the underlying condition. Consult your doctor regarding safe alcohol consumption levels.
Do not stop taking Beclomethasone Dipropionate abruptly. Sudden discontinuation can lead to a flare-up of asthma or rhinitis symptoms. If a patient has been on high doses, the healthcare provider will typically implement a tapering schedule to allow the adrenal glands to resume normal function.
> Important: Discuss all your medical conditions, especially any history of tuberculosis, untreated infections, or recent surgery, with your healthcare provider before starting Beclomethasone Dipropionate.
For each major interaction, the management strategy usually involves dose adjustment or increased clinical monitoring for systemic steroid effects.
> Important: Tell your doctor about ALL medications, including over-the-counter drugs, vitamins, and herbal products you are taking. A complete list helps prevent dangerous interactions.
Conditions requiring careful risk-benefit analysis include:
Patients who have had allergic reactions to other corticosteroids (such as Fluticasone, Budesonide, or Mometasone) may be at an increased risk of reacting to Beclomethasone. While not always cross-reactive, a history of 'steroid allergy' should be discussed with an allergist before starting treatment.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of infections or eye problems, before prescribing Beclomethasone Dipropionate.
Beclomethasone Dipropionate is approved for use in children (typically aged 4 and older for asthma, and 6 and older for nasal symptoms). The primary concern in this population is the potential for growth suppression. Clinical trials have shown that inhaled corticosteroids can cause a reduction in growth velocity (approximately 1 cm per year) in pediatric patients. To minimize this risk, the 'step-down' approach is used—titrating to the lowest dose that maintains effective control of symptoms.
Clinical studies have not identified specific differences in response between the elderly and younger adults. However, older patients are at higher risk for side effects such as skin thinning, bruising, and bone loss. Additionally, older patients may have more difficulty with the coordination required for metered-dose inhalers. Healthcare providers may recommend the use of a spacer device or a breath-actuated inhaler (like the RediHaler) to ensure proper delivery.
No formal studies have been conducted in patients with renal impairment. However, since only a small fraction of the drug is excreted renally, dose adjustments are typically unnecessary. For patients on dialysis, the drug is not expected to be significantly cleared, but systemic levels remain low enough that this is rarely a clinical concern.
In patients with severe hepatic impairment, the clearance of the swallowed portion of the drug and its metabolites may be reduced. This could lead to higher systemic levels and an increased risk of HPA axis suppression. Patients with liver disease should be monitored for signs of systemic steroid excess, such as facial swelling, easy bruising, or high blood sugar.
> Important: Special populations require individualized medical assessment to ensure the dosage is safe and effective for their specific physiological needs.
|---|---|
| Bioavailability | <20% (Inhaled systemic), ~15% (Oral) |
| Protein Binding | 94% to 96% |
| Half-life (17-BMP) | 2.8 hours (Plasma), up to 15 hours (Terminal) |
| Tmax | 0.5 to 2 hours (for 17-BMP) |
| Metabolism | Primarily via esterases to 17-BMP; CYP3A4 for further metabolism |
| Excretion | Fecal 60%, Renal 12% |
Beclomethasone Dipropionate is classified as a synthetic corticosteroid and a glucocorticoid receptor agonist. Within respiratory medicine, it is categorized as an Inhaled Corticosteroid (ICS). Related medications in this class include Fluticasone Propionate, Budesonide, and Mometasone Furoate.